Medicare Enrolled

Dr. Rose Magness, MD

Optician · Cherry Hill, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1810 HADDONFIELD BERLIN RD, Cherry Hill, NJ 08003
8567953313
In practice since 2006 (20 years)
NPI: 1003863119 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Magness from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Magness? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Magness

Dr. Rose Magness is an optician specialist in Cherry Hill, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Magness performed 507 Medicare services across 496 unique beneficiaries.

Between the years covered by Open Payments, Dr. Magness received a total of $2,134 from 26 pharmaceutical and/or device companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Magness is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 507 Medicare services $2,134 industry payments

Medicare Practice Summary

Medicare Utilization ↗
507
Medicare services
Bottom 33% in NJ for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
496
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~25 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Annual depression screening 140 $20 $63
Pelvic and clinical breast exam for cancer screening
A physical examination of the pelvis and breasts to screen for cervical or vaginal cancer. This procedure involves a clinical assessment performed by a healthcare provider.
 97 $42 $131
Stool test for blood to screen for colon tumors
A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors.
 93 $4 $14
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 84 $89 $426
Pap smear screening test
A screening test to collect and prepare a cervical or vaginal sample for laboratory analysis.
 55 $47 $146
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 38 $69 $310
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,134
Total received (2018-2024)
Avg $305/year across 7 years
Top 31% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
165
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,659 (77.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$475 (22.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$287
2023
$292
2022
$134
2021
$225
2020
$125
2019
$517
2018
$553

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$140
MAYNE PHARMA COMMERCIAL LLC
$44
Sumitomo Pharma America, Inc.
$36
Exact Sciences Corporation
$35
PFIZER INC.
$33
Top 3 companies account for 76.5% of 2024 payments
All-time payments by company (2018-2024) ›
AMAG Pharmaceuticals, Inc.
$327
Astellas Pharma US Inc
$315
Mission Pharmacal Company
$138
Evofem Biosciences, Inc.
$136
AbbVie, Inc.
$125
MAYNE PHARMA COMMERCIAL LLC
$104
Allergan Inc.
$91
Avion Pharmaceuticals
$81
TherapeuticsMD, Inc.
$80
ABBVIE INC.
$79
MAYNE PHARMA INC.
$74
Bayer HealthCare Pharmaceuticals Inc.
$72
Lupin Inc.
$69
Mylan Pharmaceuticals Inc.
$56
AbbVie Inc.
$52
Endo Pharmaceuticals Inc.
$48
PFIZER INC.
$47
Hologic, LLC
$39
Vertical Pharmaceuticals, LLC
$39
Sumitomo Pharma America, Inc.
$36
Exact Sciences Corporation
$35
Merck Sharp & Dohme Corporation
$25
Organon LLC
$19
Myovant Sciences Inc.
$19
Duchesnay USA Incorporated
$14
Agile Therapeutics, Inc.
$14
Top 3 companies account for 36.6% of all-time payments
Associated products mentioned in payments ›
ABRYSVO · ACESSA PROVU SYSTEM · Aptima · Balcoltra · CitraNatal · Cologuard Collection Kit · DIVIGEL · IMVEXXY · INTRAROSA · Kyleena · LO LOESTRIN FE · MYFEMBREE · Mirena · Myrbetriq · NASCOBAL · NEXPLANON · Natazia · Novasure · ORIAHNN · ORILISSA · Orilissa · Osphena · PREMARIN · Phexxi · Prenate Mini · SOLOSEC · TAYTULLA · TRUMENBA · Twirla · VESICARE · VYLEESI · Veozah · Xulane
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Cherry Hill?
Compare opticians in the Cherry Hill area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
620
Per 100K population
118.3
County median income
$86,384
Nearest hospital
WEST JERSEY HOSPITAL
2.8 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Magness is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Magness experienced with annual depression screening?
Based on Medicare claims data, Dr. Magness performed 140 annual depression screening services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Magness receive payments from pharmaceutical companies?
Yes. Dr. Magness received a total of $2,134 from 26 companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Magness's costs compare to other opticians in Cherry Hill?
Dr. Magness's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Magness) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Opticians in Cherry Hill
Browse opticians in Cherry Hill ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
AMAG Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from AMAG Pharmaceuticals, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Mission Pharmacal Company Payments to Doctors
See all physicians who received payments from Mission Pharmacal Company.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →